Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-26

FDA Approved: GILENYA — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved a supplemental application for GILENYA (fingolimod HCl) submitted by Novartis Pharmaceuticals Corporation. This action represents an approval o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GILENYA (FINGOLIMOD HCL)

Snippet

SUPPL AP for GILENYA (FINGOLIMOD HCL)